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. Processes that disrupt the interconnected events of fetal gonadal development, such as genetic mutations or disrupted signalling pathways, can result in reproductive dysfunction later in life. A growing body of evidence suggests that exposure to endocrine-disrupting chemicals (EDCs) early in life 2 might also contribute to the development of reproductive disorders. This idea, which was based on a growing body of experimental and epidemiological data pointing towards an increase in male reproductive disorders and fertility issues, led researchers to propose the testicular dysgenesis syndrome hypothesis back in 2001. The hypothesis proposes a common fetal origin for a group of male reproductive disorders and a possible role of fetal exposure to EDCs 3 . A growing body of evidence now also supports a corresponding relationship in women, termed the ovarian dysgenesis syndrome hypothesis [4] [5] [6] [7] FIG. 1 ). However, because of the intrinsic difficulty in retrospectively obtaining intrauterine exposure data for women who present with reproductive disorders, studies that report on clear associations between fetal EDC exposure and the ovarian dysgenesis syndrome are scarce.
One well-documented case of an EDC that affects reproductive health is that of the synthetic oestrogen diethylstilbestrol. From the 1940s and into the 1970s, clinicians prescribed diethylstilbestrol to women to reduce the risk of complications associated with pregnancy. Unfortunately, in utero exposure to diethylstilbestrol was found to cause a rare form of vaginal cancer in girls and young women, from teenage years into their twenties 8 . Subsequent studies have shown associations between intrauterine exposure to diethylstilbestrol and impaired late-life fecundity 9 and earlier age at menopause [10] [11] [12] , as well as an increased incidence of uterine fibroids 13, 14 , endometriosis 15 and reproductive-site cancers Abstract | A woman's reproductive health and ability to have children directly affect numerous aspects of her life, from personal well-being and socioeconomic standing, to morbidity and lifespan. In turn, reproductive health depends on the development of correctly functioning ovaries, a process that starts early during fetal life. Early disruption to ovarian programming can have long-lasting consequences, potentially manifesting as disease much later in adulthood. A growing body of evidence suggests that exposure to chemicals early in life, including endocrine-disrupting chemicals, can cause a range of disorders later in life, such as those described in the ovarian dysgenesis syndrome hypothesis. In this Review, we discuss four specific time windows during which the ovary is particularly sensitive to disruption by exogenous insults: gonadal sex determination, meiotic division, follicle assembly and the first wave of follicle recruitment. To date, most evidence points towards the germ cell lineage being the most vulnerable to chemical exposure, particularly meiotic division and follicle assembly. Environmental chemicals and pharmaceuticals, such as bisphenols or mild analgesics (including paracetamol), can also affect the somatic cell lineages. This Review summarizes our current knowledge pertaining to environmental chemicals and pharmaceuticals, and their potential contributions to the development of ovarian dysgenesis syndrome. We also highlight knowledge gaps that need addressing to safeguard female reproductive health.
Endocrine-disrupting chemicals
The WHO defines an endocrine disruptor as "an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)population".
Testicular dysgenesis syndrome
A collective term for male reproductive disorders (testicular germ cell cancer, cryptorchidism and some cases of poor sperm quality and hypospadias) that are hypothesized to share a common fetal origin; that is, disruptions of signalling pathways controlling early development of the male reproductive system.
Following the discovery that exposure to diethylstilbestrol in utero has detrimental effects on the reproductive health of women in later life, other associations between chemical exposures in utero and harmful effects on female reproduction have been identified. Examples include associations between maternal smoking and reduced fecundity 17 , between perfluorooctanoic acid exposure and delayed menarche 18 , and between organo chlorine pollutants (dichlorodiphenyldichloroethylene and hexachlorobenzene) and a reduced number of ovarian follicles 19 . Researchers have also reported an association between high serum levels of bisphenol A (BPA) and an increased risk of polycystic ovary syndrome (PCOS); however, the precise pathological mechanisms are unclear 20 . These associations in humans are supported by animal studies, which have revealed similar effects. For example, developmental exposure to chemicals with oestro genic or anti-androgenic activity can reduce the follicle pool in rodents [21] [22] [23] [24] , which can lead to a shortened reproductive lifespan. When extrapolated to humans, these data suggest that oestrogenic or anti-androgenic compounds might not only affect the ability of a woman to have children but also increase the risk of developing associated ailments, such as osteoporosis and cardiovascular disease 25 . Disruption to fetal development can have dire consequences for postnatal life. However, in the case of lateonset female reproductive diseases, such as subfertility, PCOS or premature menopause, a causative link is difficult to establish because the initiating events occur much earlier than when the adverse phenotypes are observed. Providing direct evidence for the ovarian dysgenesis syndrome hypothesis in human patients is particularly difficult, but controlled animal experiments have been useful in clarifying the relationship. For example, prenatal and perinatal exposures of rats and mice to EDCs result in disruption of endocrine-sensitive tissues and organs in female offspring later in life 21, 23, 24, [26] [27] [28] [29] , which largely phenocopy corresponding human disorders.
In this Review, we discuss possible actions of chemicals on the developing ovary. Among the many environmental chemicals and pharmaceuticals that humans can be exposed to, a subgroup have endocrine modes of action -that is, they act as EDCs -whereas other chemicals affect the ovary through non-endocrine pathways, yet disrupt ovary function. We focus on four potentially sensitive time windows during ovarian development: gonadal sex differentiation, meiosis, follicle assembly and early folliculogenesis (FIG. 2) . To highlight these sensitive windows, we have limited this Review to studies with short exposure periods during specific developmental phases. Therefore, we have omitted several studies that used longer exposure periods, such as the entire gestational and lactational period. Some animal studies on chemical exposures have investigated doses that are higher than the average levels of exposure generally seen in humans, which we will discuss when relevant. However, one should keep in mind that, during sensitive developmental windows, even short-term exposure can have irreversible consequences for female reproductive health.
Early gonadal development
The primordial germ cells originate in the proximal epiblast during gastrulation, far from the testes or ovaries, and thus have to migrate through the developing fetus before taking up residence in the primitive gonadal structures 30 . At this stage of development, the gonadal ridges are still bipotential, and they remain so until gestational week 7 in humans and approximately halfway through gestation in rats (~12 days post coitum) and mice (~11 days post coitum) 31 . The expression of the Y chromosome-specific gene Sry in XY gonadal ridges triggers the differentiation of the gonadal ridges into testes, whereas, in the absence of a Y chromosome or more specifically of Sry, the XX gonadal ridges differentiate into ovaries 32 . The differentiation of testes and ovaries is chiefly under genetic control and involves several antagonizing morphogenetic pathways 31, [33] [34] [35] ; nevertheless, research suggests that these early processes could be vulnerable to exogenous perturbation 36 . Studies that investigate the potential effects of chemicals on primordial germ cells and gonadal sex differentiation are scarce, but some do exist (TABLE 1) . One such chemical that researchers have investigated is paracetamol, which is a mild analgesic and antipyretic drug also known as acetaminophen. The active ingredient derives from N-acetyl-para-aminophenol. In one study 37 , intrauterine exposure to paracetamol from 7 days post coitum reduced the number of germ cells in female mouse fetuses as early as 13.5 days post coitum. The probable cause was perturbed proliferation of the primordial germ cells (FIG. 2a) . The researchers also reported that exposure to paracetamol from 7 days post coitum until birth resulted in a reduction in ovarian follicle reserves and total number of follicles, which led to subfertility at 10 months of age 37 . By exposing mouse embryonic stem cells to paracetamol, the same researchers showed an apparent decrease in mitotic activity, which could point towards a mechanism by which paracetamol can limit oocyte numbers at birth. Of note, fetal germ cells express cyclooxygenase 2 and prostaglandin E2 receptor 38, 39 , both of which are targets of paracetamol. The mechanisms by which paracetamol interferes with the germ cells, either directly at the molecular level or indirectly by affecting supporting somatic cells, are unclear. Paracetamol can also affect the later stages of follicle development 39, 40 . Appropriate mechanistic studies are important avenues to pursue in future studies.
Key points
• Humans are continuously exposed to numerous chemicals, including endocrine-disrupting chemicals (EDCs), throughout life • The ovarian dysgenesis syndrome hypothesis proposes that exposure to certain chemicals, including EDCs, during fetal life can lead to reproductive disorders later in life • Female fetuses are particularly sensitive to chemical exposure during four developmental windows: early gonadal development, meiotic division of germ cells, follicular assembly and early follicle recruitment • Some human epidemiological data suggest that the incidence of female reproductive disorders has increased since the mid-1950s and that EDCs are potential contributors
Cohesin complex
A multisubunit protein complex responsible for cohesion between sister chromatids during both mitosis and meiosis. It is also central to DNA double-strand break repair, especially in meiotic cells.
Synaptonemal complex
A meiosis specific structure composed of multiple proteins that connect homologous chromosomes during prophase I.
One study that investigated the effects of exposure to tamoxifen on gonadal development provided further evidence for the hypothesis that this developmental stage is vulnerable to exogenous perturbation. Mice that were exposed at 10.5 days post coitum to tamoxifen, an oestrogen receptor (ER)-modulating pharmaceutical that is used for the treatment of breast cancer, displayed disrupted gonadal sex differentiation. Tamoxifen seemingly induces these adverse effects by ectopic upregulation of Sox9 and downregulation of Foxl2 in the XX gonads, as seen 13.5 days post coitum 41 (FIG. 2a) . Sox9 is the key factor that is transactivated by Sry in the XY gonadal ridges and is both necessary and sufficient to ensure proper differentiation of the testes 31 . One way in which Sox9 ensures testis differentiation, apart from transactivating pro-testis genes, is by suppressing pro-ovary factors, such as Foxl2 within the pre-Sertoli cell population 42, 43 . Disrupting the balance between these opposing factors can lead to sex-reversal phenotypes and cause reprogramming of the cell types in adulthood [44] [45] [46] [47] . Sexual reprogramming of the gonadal supporting cells in this way will adversely affect the germ cell population, ultimately leading to infertility. Notably, FOXL2 mutations in humans cause premature ovarian insufficiency 48 , emphasizing the importance of this protein in female reproduction. Interestingly, in adult mice, the repressive activity of Foxl2 towards the expression of Sox9 synergistically increases in the presence of ERα 46 . Furthermore, mice that are deficient in both ERα and ERβ have a phenotype that is similar to that of mice with Foxl2 mutations 49 . These data imply that ERs have an important role in sustaining the integrity of the ovary during fetal life, as they are expressed in the human (only ESR2 (which encodes ERβ)) and rodent fetal ovary 50, 51 . However, whether the mechanism of action that causes the effects is due to interference with ERs remains unclear 41 . The industrial chemical BPA, which is widely reported to have oestrogenic and other endocrine-disrupting properties, reportedly also interferes with gonadal development. In mouse embryonic stem cells, exposure to BPA results in the downregulation of the testis-promoting genes Sox9 and Fgf9 and in the upregulation of the ovarypromoting genes Wnt4 and Foxl2 during differentiation 52 (FIG. 2a) . These data could suggest that exposure to BPA favours ovary differentiation; however, it remains unclear whether the findings translate to gonadal development in intact animals and at human-relevant dose levels.
As paracetamol and tamoxifen are pharmaceuticals, humans could be exposed to high doses over short periods of time throughout life. In the case of paracetamol, owing to its indication for use, pregnant women could be exposed to doses that are similar to those reported to affect fetal gonadal development in mice 37 ; however, as tamoxifen increases the risk of congenital malformations, its use is not recommended during pregnancy. In the context of explaining risk factors for ovarian dysgenesis, however, tamoxifen is a model compound because it has ER-modulating actions. Nevertheless, this evidence suggests that in utero exposure to chemicals can result in adverse effects on the future oocyte reservoir and reproductive lifespan, a worrying scenario that warrants far more attention than it presently receives.
Meiosis
Meiotic division is unique to germ cells and occurs at different developmental stages in males and females. In males, meiosis starts at puberty and continues throughout adulthood, whereas, in females, meiosis starts during fetal life and arrests in prophase I until puberty 53 . In female mice, meiosis initiation occurs 13.5 days post coitum through the action of retinoic acid 54, 55 . The initiation of meiosis triggers a chain of events whereby the germ cells are primed for oogenesis by entering the first phase of meiosis in utero 56 . Disruption of germ cells at this stage can have long-lasting consequences for reproductive health parameters due to: reduction in the number of oocytes through defective recombination 57 ; loss of oocytes resulting from the lack of REC8, an important component of the cohesin complex 58 ; or loss of oocytes and creation of aneuploid gametes attributable to altered expression of synaptonemal complex protein 3 (SYCP3) 59 . Evidence suggests that chemicals can interfere with some of these processes (TABLE 2) . For example, EDCs that interfere with oestrogenic activity 28 are hypothesized to have adverse consequences for the quality and quantity of germ cells in the adult female, ultimately affecting fertility and reproductive lifespan.
In 2003, researchers at Washington State University noted a spontaneous increase in meiotic spindle misalignments and an increased rate of aneuploidy in control female mice; that is, the expected normal rate was inexplicably increased. After investigating the source of this abnormal phenotype in what should be healthy control animals, the investigators discovered that damaged cages and water bottles were leaching BPA 60 . The finding spurred additional investigations, and data now suggest that BPA can disrupt meiotic division in mice and monkeys 28, 61 . The effect is believed to be caused by BPA antagonizing ERβ, as ERβ-knockout mice have almost identical defects to those seen in BPA-exposed mice 28 (FIG. 2b) . Of note, the human fetal ovary only expresses ERβ, not ERα 62 . Exposure to BPA beginning 12.5 days post coitum has also been associated with a delay in prophase I 17.5 days post coitum in mice, which could result from a reduced expression of Stra8 (FIG. 2b) , possibly due to increased methylation 63 . Exposure to a low dose of BPA in vivo also results in subtle changes in the expression of other genes that are involved in meiosis 64 , which warrants further investigation.
Box 1 | Ovarian dysgenesis syndrome hypothesis
Unlike gonadal dysgenesis, in which the ovaries or testes fail to form altogether (such as streak gonads), ovarian dysgenesis is specific to female reproduction and refers to conditions in which the ovaries are underdeveloped or imperfectly formed. The result of ovarian dysgenesis is compromised reproductive development or function. Ovarian dysgenesis syndrome is defined as early alterations in ovarian structure or function that cause an impairment of reproductive parameters in adulthood 4, 5 . The ovarian dysgenesis syndrome hypothesis proposes a common origin for a group of related female reproductive diseases and disorders, such as reduced fertility, polycystic ovary syndrome, premature ovarian insufficiency and reproductive-site cancers. Several potential causative events have been identified, including genetic and environmental factors, which result in reproductive health issues later in life. Data also indicate that di(2-ethylhexyl) phthalate (DEHP) can affect meiotic progression. For example, one study showed delayed meiotic progression 17.5 days post coitum in mouse fetuses that were exposed to DEHP in utero 65 . This change probably relates to delayed initiation of meiosis, as the mice had considerably reduced expression of STRA8 13.5 days post coitum, at both mRNA and protein levels (FIG. 2b) .
Evidence suggests that the mild analgesics paracetamol and indomethacin can also interfere with meiosis. Female rat fetuses that were exposed to paracetamol (350 mg/kg per day, from 13.5 to 21.5 days post coitum) or indomethacin (0.8 mg/kg per day, from 15.5 to 18.5 days post coitum) have a reduced number of germ cells 21.5 days post coitum. These adverse effects might be caused by a delay in meiotic entry or progression, culminating in reduced ovary weight and fertility in adulthood 39 (FIG. 2b) . The idea that analgesics can have endocrine-disrupting properties and potentially affect reproductive development of fetuses exposed through their mother has been around for some time, but research has typically focused on male development 40 . However, the fact that the developing germ cells might be susceptible to perturbation by analgesics at human-relevant doses adds another level of concern for the often indiscriminate use of over-the-counter mild analgesics even during pregnancy.
Taken together, the available evidence suggests that both industrial chemicals and pharmaceuticals can adversely affect early oocyte development in mammals. Mechanisms are hypothesized to include the disruption of meiotic recombination and synapsis 28, 57 or a delay in meiotic progression 65 , all of which ultimately affect the reproductive capacity of the offspring (TABLE 2) . Further studies aiming to decipher the relevance of these findings to humans are warranted, but the dose levels of BPA and DEHP that affect meiosis in mice and monkeys are low 61, 64, 65 and within the human exposure range [66] [67] [68] . Although the effects observed in mice that were exposed to paracetamol occur at much higher doses than those of BPA and DEHP, they are also similar to human exposure levels during short-term therapeutic use. Interestingly, chemical exposure can also affect female reproductive development during late-gestation and postnatal stages, as discussed in the following section.
Follicle assembly
After colonizing the gonads during fetal life, female germ cells quickly arrange into germ cell nests 69 . Towards the end of gestation in mice, 2-3 days before birth, germ cell nests within the medullary region of the ovary break down, resulting in a decrease in the number of oocytes and the beginning of primordial follicle formation 70 . By contrast, the breakdown of germ cell nests within the ovarian cortex starts shortly after birth 71 . Although the exact mechanisms that are involved are unknown, somatic pre-granulosa cells contribute by intruding between closely associated germ cells, thereby establishing single cells surrounded by pre-granulosa cells, called primordial follicles 71 . Concurrently, a large proportion of the germ cells undergo programmed cell death, a process that involves both autophagy and apoptosis 72, 73 . By 4 days postpartum, approximately one-third of the original oocyte reserve remains 70, 71 . In rodents, follicle assembly continues until postpartum day 6, after which almost all of the remaining oocytes are enclosed within primordial follicles 71 . In humans, the timing of primordial follicle assembly is very different from that of rodents, with follicle assembly occurring during mid-gestation stage (FIG. 3) . The processes involved -nest breakdown, germ cell death and formation of primordial follicles -are similar 74 but much less spatially organized than they are in rodents. However, the initiating mechanisms might be different, especially considering that follicle assembly takes place at very different stages of development in humans (prenatally) and rodents (postnatally). By extension, when extrapolating data from one species to another, one should consider these differences when evaluating studies in rodents on chemically induced changes in germ cell development.
EDC exposure and follicle assembly. The mechanisms that control follicular assembly remain unclear. Evidence suggests that, in mouse fetuses, high levels of maternal oestradiol and progesterone inhibit follicle assembly and that a reduction in the levels of steroid hormone around the time of birth initiates the process [75] [76] [77] . The opposite situation is seen in non-human primates; follicle assembly occurs during gestation, as it does in humans, and a reduction in levels of oestrogen inhibits follicle assembly 78 . Furthermore, the human fetal ovary expresses steroidogenesis enzymes and steroid hormone receptors, particularly ERβ, during the second trimester, which enables oestrogenic, progestogenic and androgenic signalling to occur 62, 79 . These data indicate that oestrogen has an important role in follicle assembly but also highlights the potential susceptibility to disruption by oestrogenic compounds that interfere with normal oestrogen signal transduction. Indeed, maternal cigarette smoking, which lowers adult fecundity in their offspring, is associated with both increased levels of oestrogen in the human fetus and accelerated onset of primordial follicle formation 80 . The opposing effects of oestrogen on different species also suggest that EDCs have unique effects on germ cells depending on the species involved (TABLE 3) ; nevertheless, several studies support the hypothesis that oestrogenic chemicals delay initiation of follicular assembly in rats and mice (FIG. 2c) .
Figure 2 | Germ cell development and chemical exposure in mice. a | In mice, the primordial germ cells colonize the primitive gonads from around 10 days post coitum and arrange into germ cell nests. From 11 days post coitum, the gonads differentiate into either testes or ovaries in XY and XX embryos, respectively. In the ovaries, meiosis is initiated at around 13.5 days post coitum and progresses until prophase I. Around birth, follicle assembly is initiated and continues to about 6 days postpartum. Now, almost all oocytes are enclosed within primordial follicles. Early follicle recruitment is then initiated and continues until around 3 months of age, after which the second wave of follicle recruitment is initiated. b | Paracetamol is associated with reduced proliferation of germ cells, which can cause a decrease in the number of oocytes in the adult ovaries. Gonadal sex differentiation is also sensitive to perturbation, and tamoxifen can disturb the balance between the expression of male and female specific genes and proteins in the XX gonad (future ovary). c | Meiotic progression is delayed following exposure to bisphenol A (BPA) or di(2-ethylhexyl) phthalate (DEHP), which might result from the reduced expression of Stra8 mRNA (BPA or DEHP) and protein (DEHP). BPA might also antagonize oestrogen receptor β (ERβ), thereby leading to synaptic aberrations and increased levels of recombination. Furthermore, paracetamol can delay meiotic progression. d | Follicle assembly is crucial for establishing the primordial follicle pool. Several chemicals including BPA and DEHP can interfere with this process, possibly by disrupting apoptotic signalling pathways. e | The first wave of follicular recruitment is initiated immediately after the primordial follicle pool has been established. BPA, DEHP or the DEHP metabolite monoethylhexyl phthalate (MEHP) can all accelerate the rate of follicular recruitment. FOXL2, forkhead box protein L2; MOFs, multi oocyte follicles; STRA8, stimulated by retinoic acid gene 8.
Exposure of fetuses to oestrogenic chemicals through the pregnant dam adversely affects the offspring. Oral exposure of pregnant mice to 80 μg/kg of body weight per day of BPA from 12.5 to 18.5 days post coitum results in an increased percentage of oocytes in germ cell nests, an increase in the total number of oocytes per ovary section and a decrease in the number of primordial follicles in offspring 3 days postpartum 63 . Another study on oral exposure of rat dams to 0.5 μg/kg, 20 μg/kg or 50 μg/kg of bodyweight per day of BPA from 11 days post coitum until birth showed an increase in the number of oocytes in nests at all doses and a decreased percentage of primordial follicles in the groups that were exposed to 0.5 μg/kg and 50 μg/kg of bodyweight per day 29 . In a small study of rhesus macaques, oral or continuous (by silastic tube) exposure to BPA from gestation day 100 to term seemed to disrupt follicle assembly in the neonatal offspring 61 . This finding in primates supports a possible effect of BPA in humans; however, the study is rather small and warrants further investigations. Neonatal exposure to oestrogenic chemicals can delay follicle assembly and might affect the primordial follicle pool differently depending on species. For example, subcutaneous exposure of neonatal mice to the phytooestrogen genistein inhibits the breakdown of the germ cell nest and disrupts primordial follicle assembly, thus reducing the number of primordial and primary follicles 4 days postpartum, and increasing survival and the total number of oocytes 76 . Similarly, subcutaneous exposure of neonatal mice from 1 to 5 days postpartum to the synthetic oestrogens diethylstilbestrol, ethinyl oestradiol and BPA seems to inhibit nest breakdown, increase the total number of oocytes and increase the percentage of primordial follicles when measured 5 days postpartum 81 . The opposite effect is observed in rats. A decrease in the number of primordial follicles 8 days postpartum was reported in rat pups exposed to diethylstilbestrol (0.2 μg/kg or 20 μg/kg of bodyweight per day) or BPA (20 mg/kg of bodyweight per day) 1, 3, 5 and 7 days postpartum 23 , as well as 3 and 6 days postpartum in rat pups treated with oestrogen between 0 and 2 days postpartum 82 . These data suggest that mice and rats are affected differently. Data from studies on hamsters suggest that neonatal oestrogen exposure stimulates follicle assembly at low, but not at high, doses 83 . Collectively, oestrogenic chemicals, including BPA, can affect the oocytes of different species. In mice, the effects of BPA on the breakdown of the germ cell nest and the total number of oocytes are the same regardless of whether exposure occurs during fetal or neonatal periods 63, 81 . By contrast, exposure during fetal or neonatal periods has opposing effects on the number of primordial follicles formed 63, 81 . For all of these studies, differences in the timing of exposure, dose levels and the time at which the ovaries are examined led to the marked differences in effects, particularly as follicle assembly is a dynamic event and the distribution of oocytes and/or follicles varies within a few days. DEHP causes effects that are similar to those triggered by BPA. For example, DEHP increases the number of germ cell nests and decreases the number of follicles in newborn mice following oral exposure of pregnant dams or by injecting neonates 65, 84 , suggesting a delayed follicle assembly (FIG. 2c) . Neonatal (1 to 7 days postpartum) subcutaneous exposure to propylparaben and butylparaben can also affect follicle numbers, leading to an increased number of primordial follicles and a decreased number of early primary follicles 85 . The effect of these paraben compounds on follicle numbers is thought to be due to the inhibition of initial follicle recruitment, but, as exposure started 1 day postpartum, incorrect follicle assembly cannot be excluded; specifically, a delay in follicle progression.
In vitro culture studies show that neonatal mouse ovaries typically undergo effects that resemble those observed after in vivo exposure, such as increased number of germ cell nests and altered number of follicle (TABLE 3) . These in vitro effects were seen in response to exposure to: genistein from 1 to 7 days postpartum 75 ; BPA from 0 to 3 days postpartum 86 ; BPA from 0 to 8 days postpartum 87 ; DEHP from 0 to 3 days postpartum 86 ; and DEHP from 16.5 days post coitum to 3 days postpartum 84 . An extensive study in sheep added further evidence to the notion that the period of time during which follicle assembly takes place is a particularly sensitive window for chemical exposure. During the study, pregnant ewes were exposed to a mixture of environmental chemicals, including EDCs, during early, mid, late or the entire gestation period. The researchers reported disrupted fetal folliculogenesis in all exposure groups and attributed the effects to disrupted follicle assembly. However, the most pronounced changes to gene and protein expression were reported in fetuses that were exposed to these environmental chemicals during mid-late gestation 88 . Taken together, these studies support the view that many EDCs can have an inherent capacity to disrupt follicle assembly, potentially affecting both the quantity and quality of follicles later in life (TABLE 3) . However, whether such effects occur at human-relevant dose levels remains unknown.
Mechanisms that affect follicle assembly. One mechanism that might help to explain the observed effects on follicle assembly following chemical exposure is apoptosis. The reduction in total number of oocytes caused by programmed cell death is an integral part of normal ovary development 89 . By disrupting this process, chemicals can affect overall ovarian function. Endogenous oestrogen can reduce apoptosis in the adult ovary 90 , and thus EDCs with oestrogenic potential might prevent apoptosis at perinatal and neonatal stages (FIG. 2c) . Two studies support this hypothesis; data show that subcutaneous exposure of neonatal mice to genistein, diethylstilbestrol, ethinyl oestradiol or BPA results in a reduction in the number of oocytes undergoing apoptosis 76, 81 . In a different study, co-administration of an ER antagonist and DEHP to explanted ovaries prevented the increase in the number of oocytes in germ cell nests and the decrease in the number of primordial follicles that were observed following exposure to DEHP alone 84 . Furthermore, exposure to BPA from 11 days post coitum until birth increases the expression of anti-apoptotic factors but decreases the expression of pro-apoptotic factors 29 , results that are largely recapitulated when explanted ovaries are exposed to BPA 87 (FIG. 2c) .
The opposite effect -an increase in the number of apoptotic germ cells -has been seen in explanted ovary cultures exposed to BPA or DEHP for 3 days 86 . However, increased rates of apoptosis could be due to cytotoxicity, as the effective dose was more than the double of the dose used in previous studies 87 . The reduction in the number of germ cells could also result from reduced proliferation, as it has been observed in human fetal ovaries exposed to a bioactive component of cigarette smoke in vitro 91 , or from a combination of disrupted apoptosis and proliferation. Further studies aimed at improving the delineation of these processes in relation to chemical exposures would be of great interest.
The current consensus is that, in rodents, meiotic progression and primordial follicle assembly are related. The initiation of follicle assembly occurs when oocytes in the neonatal ovaries reach the end of prophase I (diplotene stage) 92 . Exposure to BPA might delay meiotic progression through prophase I, possibly reducing Stra8 expression, which could explain the observed reduction in the number of assembled primordial follicles shortly Germ cell development -from the migration of primordial germ cells to the gonadal anlagen during embryogenesis through to folliculogenesis -in the developed ovaries is similar in mice and humans. However, differences exist in terms of the developmental stage during which follicle assembly and the first wave of follicle recruitment take place. In humans, follicle assembly is initiated around gestation week 17, whereas, in mice, it is initiated around the time of birth. As the first wave of follicle recruitment follows immediately after follicle assembly, this process is also initiated during fetal life in humans, whereas, in mice, it is initiated after birth (around 6 days postpartum). GW, gestational week. . However, to pinpoint the mechanism that underlies the follicular phenotype based on the reduction in Stra8 expression alone is difficult, as reduced expression of Stra8 could indicate that fewer oocytes are present overall, that fewer oocytes have entered meiosis or that most oocytes have already progressed through meiosis.
Early follicle recruitment
Exposure to BPA, paracetamol or other EDCs during both fetal and postnatal life can adversely affect the follicle reserve, and even folliculogenesis itself 22, 93, 94 . However, owing to the extensive differences in the developmental periods during which exposures occurred in such studies, deducing specific sensitive time windows is often difficult. In this section, we focus on studies that deal with exposure occurring after follicle assembly and up to puberty or, more specifically, during the first wave of folliculogenesis.
As opposed to the developing human ovary, where primordial follicles typically localize in the cortex, mouse primordial follicles form in both the medulla and the cortex. Immediately after formation, primordial follicles of the medulla activate and constitute the first wave of follicles. This first wave dominates the ovary up until 3 months postpartum and seems to be involved in the onset of puberty and the activation of the hypothalamicpituitary-gonadal axis, as well as to influence fertility during young adulthood. After 3 months of age, the second wave of follicles is recruited from the cortical region and functions as the oocyte pool for the remainder of the reproductive lifespan 95 . DEHP and its main metabolite monoethylhexyl phthalate (MEHP) can stimulate follicle recruitment both in vivo and in vitro. A decrease in the number of primordial follicles, concomitant with an increase in the number of secondary and antral follicles, has been observed in 15-day-old mice after exposure to DEHP from 7 to 14 days postpartum and in 21-day-old mice after single-day exposure to DEHP 5, 10, 15 or 20 days postpartum 24 . In this study, mice were exposed to DEHP after follicle assembly was completed, so the reduction in the number of primordial follicles could have been ; ↓ healthy post-primordial transitory follicles; ↑ atretic post-primordial transitory follicles; ↓ atretic primordial follicles; 33 differentially expressed transcripts BP, butylparaben; DEHP, di(2-ethylhexyl) phthalate; EE, ethinyl oestradiol; ER, oestrogen receptor; GD, gestational day; Ha, hectare; MP, methylparaben; MOFs, multi oocyte follicles; PP, propylparaben; SC, subcutaneous injection; ↓, decrease; ↑, increase; ↔, no change.
Disorders of sex development
Congenital conditions in which chromosomal, gonadal or anatomical sex is atypical.
caused by increased recruitment of first-wave follicles. However, one cannot rule out that direct effects on the oocytes caused increased cell death and the consequent reduction in the number of oocytes, as the total numbers of oocytes was not reported. Another study supports a stimulatory effect of DEHP on follicle assembly or recruitment. When cultured mouse ovaries were exposed to MEHP from 4 to 10 days postpartum, the percentage of oocytes not encapsulated in a follicle decreased, whereas the percentage of primary follicles increased, without affecting the percentage of primordial follicles 96 . This stimulatory effect of exposure to DEHP or MEHP could be caused by activation of the phosphoinositide 3-kinase (PI3K) pathway.
In oocytes, PI3K is negatively regulated by phosphatase and tensin homologue (PTEN). In mice that lack PTEN, levels of phosphorylated AKT (pAKT) are increased, and the entire primordial follicle pool is activated, causing depletion of primordial follicles and resulting in premature ovarian failure 97 . Interestingly, one study 96 found a reduced percentage of PTENpositive oocytes and an increased percentage of pAKT-positive oocytes in the MEHP-exposed ovary explants, indicating that the observed changes were indeed due to increased follicle recruitment. Of note, however, is that the primordial follicle pool in the study was unaffected when the number of PTEN-positive oocytes decreased. One explanation for this finding could be that the period between increased follicle recruitment and examination of the number of primordial follicles 10 days postpartum was not long enough to observe an effect. Indeed, the ovary explants in this study 96 were cultured for a shorter period of time than in other studies 24 in which a reduction in the number of primordial follicles was not observed at a later stage, 15 or 21 days postpartum 24 . BPA might also affect early folliculogenesis. In sheep, as in humans, follicle assembly is completed in utero. Following exposure to BPA from 1 to 14 days postpartum, 30-day-old lambs had reduced ovary weight, fewer primordial follicles, more transitional and primary follicles, but a stable total number of oocytes compared with lambs that were not exposed to BPA 98 . These data indicate that the recruitment of primordial follicles increased in response to exposure to BPA 98 . Taken together, these studies suggest that DEHP and BPA can increase the recruitment of follicles from the primordial follicle pool during early folliculogenesis (FIG. 2d) . Increases in follicle recruitment can have consequences later in life, such as a shorter reproductive lifespan due to a reduced number of primordial follicles. These observations are concerning, especially if these effects also occur at human exposure levels. Only a few available studies have investigated exposure to EDCs limited to the postnatal period, and more studies are required to improve our understanding of the mechanisms behind the observed effects.
Chemical exposure and reproductive health
On the basis of animal experiments, little doubt remains that exposure to chemicals, including EDCs, can affect ovarian development and function. However, whether the same chemicals cause similar effects in humans at doses that are relevant to real-life exposure remains unclear. Although controversial and sometimes disputed, some studies indicate that, over the past few decades, populations of industrialized countries all over the world have experienced a decline in total fertility rates, measured as live births per woman 99 . Although this decline, of course, can be partly explained by changing attitudes towards family planning and by the increased use of contraceptives, as well as other social changes, alterations to the biochemical environment might also contribute. The increasing chemical burden in the human population could also be contributing to the increase in women reporting difficulties with conceiving and maintaining pregnancy, as now described for women of all ages 100, 101 . Historical data show that chronological age is a determining factor for fertility but is of limited importance until 35 years of age 102, 103 ; therefore, chronological age alone cannot explain the accelerated biological ageing of the ovary that is observed before the age of 35 years. Insights from widespread medical use of assisted reproductive techniques indicate that a combination of environmental and genetic factors can contribute to reduced quality of the oocyte pool with age 104, 105 . Chemicals such as para,paraʹ-dichlorodiphenyltrichloroethane (p,pʹ-DDT) 106 , fluorinated chemicals 107 and pesticides 108 are all associated with decreased fecundability, assessed as self-reported time to pregnancy. Furthermore, BPA and other EDCs are associated with the development of PCOS, one of the leading causes of subfertility 20 . An increase in prematurity, pre-eclampsia, gestational diabetes mellitus and premature puberty has also been reported since the middle of the 20th century 100, 101 . This decline in reproductive health has occured over a short period of time, less than 100 years, which makes genetic changes an improbable explanation 100, 101 , and some have suggested that EDCs are potential contributors 101 . Cancers of the reproductive organs and tissues represent an aspect that has not been covered in detail in this Review. A clear causation between early exposure to EDCs and gynaecological cancers is lacking, but a meta-analysis published in 2017 concluded that infertile women have a greater risk of developing endometrial cancer than the general female population 109 . By contrast, data concerning a potential increased risk of developing breast or ovarian cancer in infertile women are conflicting 109 . Interestingly, a study published in 2016 reported an association between irregular menstrual cycling, in many cases caused by PCOS, and ovarian cancer 110 . Another class of cancers, malignant ovarian germ cell tumours, is of special interest in the light of exposure to EDCs, as these tumours are believed to originate from fetal pluripotent germ cells 111 . These cancers share much of their aetiology with the equivalent cancer in men, testicular germ cell tumours, which arise from genetic aberrations, but the development of these tumours is probably also influenced by environmental factors during early developmental stages 112 . In fact, patients with disorders of sex development 113, 114 have an increased risk of developing germ cell tumours, which attests to the importance of the somatic environment, and not only of intrinsic factors, in the regulation of germ cell development 115 .
Human exposure levels
Several biomonitoring studies have measured levels of BPA in urine for the calculation of human exposures. In the USA and Europe, median exposure to BPA ranges between 0.03 μg/kg and 0.04 μg/kg of bodyweight per day for adults; however, approximately 5% of the population is exposed to more than 0.15 μg/kg of bodyweight per day [66] [67] [68] . Somewhat higher dose levels were estimated in a comprehensive report by the European Food Safety Authority, who estimated mean and high dietary exposure levels of 0.1 µg/kg and 0.4 µg/kg of bodyweight per day of BPA, respectively 116 . Several animal studies have indicated that BPA affects ovary development at doses of ~20 μg/kg of bodyweight per day and, in some studies, even in a dose range of ng/kg of bodyweight per day (TABLES 2, 3) . These data indicate a no-effect level below ~20 μg/kg of bodyweight per day in animals. In terms of human risk assessment, a 100-fold difference (safety margin) between no-effect levels in animal studies and human exposure levels is generally required before the human exposure levels are considered safe. Therefore, in the case of BPA, the margin of safety could be below 100-fold for the most highly exposed persons, if the reported findings truly reflect adverse changes in ovary development at low BPA doses.
Researchers typically use urinary DEHP metabolites, including MEHP, to retrospectively estimate actual exposure to DEHP. Estimates show that humans are exposed to ~1.5 μg/kg of bodyweight per day of DEHP in Europe and 4 μg/kg of bodyweight per day in the USA 68, 117 . For around 5% of the population, the levels exceed 4.4 μg/kg and 34 μg/kg of bodyweight per day in Europe and the USA, respectively 68, 117 . Effects on ovary development have been observed following exposure to 20 μg/kg of bodyweight per day and 40 μg/kg of bodyweight per day in some animal studies, indicating that the no-effect level is <20 μg/kg of bodyweight per day (TABLES 3, 4) . Thus, no (or very low) safety margin is currently in place for a large proportion of the population if these findings reflect true adverse changes in ovary development at low doses of DEHP, and possibly other phthalates as well. However, these safety evaluations should be based on a larger evidence base and preferably include studies that examine more doses to enable dose-response characterization.
The use of paracetamol has become widespread, and research suggests that >50% of women use paracetamol at some point during pregnancy 118 . In Denmark, 0.2% of women use paracetamol every day during early pregnancy, whereas 0.7% of women use it once or twice per week 119 . In addition, exposure to paracetamol is almost ubiquitous in many populations, even when no use is reported 40 . In Germany, paracetamol has been detected in persons who had neither consumed paracetamol within the previous week nor been occupationally exposed to its precursor aniline, indicating that other unknown exposure sources exist 120 . A Danish study reported similar exposure data, according to which mothers and their children had similar levels of paracetamol in their blood despite no obvious exposure source 121 . To date, no clear associations between developmental exposure to paracetamol and effects on human female reproductive health have been reported. Strikingly, the dose levels that affect ovary development in mice (50 mg/kg of bodyweight per day) are similar to exposure levels of humans taking the maximal recommended dose of paracetamol, even when not correcting for differences in metabolism between rats and humans 37 . Between species, fetal development differs in timing relative to the gestational period. In humans, follicle assembly takes place during fetal life, whereas in rats it occurs neonatally 74 . As previously mentioned, the first wave of folliculogenesis initiates immediately after follicle assembly, the timing of this process also differs between humans and rats or mice (FIG. 3) . Ultimately, these differences in timing mean that, for humans, gestational period is the most susceptible period for exposure with regards to follicle assembly. What further complicates the picture is that humans are continuously exposed to numerous chemicals, including EDCs, at any given time 122 , whereas controlled animal experiments typically involve exposure to single chemicals during specific time windows. To overcome this hurdle, researchers carried out a series of studies in sheep on pastures. The investigators exposed sheep to a mixture of environmental chemicals before and during pregnancy 88, 123, 124 . The studies that focused on female fetuses concluded that continuous maternal exposure to a low-concentration mixture of chemicals can disrupt ovary development 123 and that exposure during mid and late gestation was most detrimental 88 . Furthermore, the investigators reported that the pre-conception period is important in relation to outcomes for the offspring 124 . Finally, a change in exposure between the pre-conception and post-conception periods seemed to have a greater effect on fetal ovary development than a continuous exposure 124 .
To date, studies on mixture effects -the combined effect of several chemicals -have focused on male reproduction, and the combination of certain EDCs is reported to contribute to more pronounced effects than individual chemicals at the same doses 125, 126 . Similar scenarios for female reproduction are probable, with some studies reporting additive effects, mainly with combined exposure to phyto-oestrogens [127] [128] [129] . Low doses of several EDCs that affect the ovary, including DEHP, BPA and paracetamol, could therefore produce effects at exposure levels that are considered safe for individual compounds.
Conclusions
Since the mid-1900s 130 , the prevailing view of mammalian sex differentiation has been that male fetuses are crucially dependent on sex hormones for masculinization, whereas female fetuses develop largely independently of sex hormones. Consequently, studies aimed at elucidating effects of EDCs on fetal development, including long-lasting consequences manifesting in adulthood, have primarily focused on males. However, strong indications exist suggesting that females are not protected from the potential harm caused by exposure to EDCs, even in utero.
In this Review, we have highlighted the potential links between developmental exposure to EDCs and effects on reproductive health later in life, with a focus on ovarian development and function. To highlight the most sensitive time windows, we have limited this Review to studies with short exposure periods during specific developmental phases. From our synthesis, many questions remain unanswered, but we believe that four specific time windows warrant particular focus. First, early germ cell development and gonadal sex differentiation are processes that are not normally associated with subtle disruptions caused by chemical exposure. However, the pharmaceuticals paracetamol and tamoxifen might interfere with these processes. Similarly, BPA might disturb the molecular pathways that determine the balance between the male and female cell fates in the testes and ovaries. As disrupted sex differentiation can have far-reaching consequences for the individual, this area of research requires a much stronger emphasis, and to date very few studies have focused on this early period of development.
Second, meiosis is a process that is unique to germ cells, and correct progression is crucial for the quality and quantity of germ cells in the adult female. The industrial chemicals BPA 28, 61, 63 and DEHP
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, and the pharmaceuticals paracetamol and indomethacin 39 , can disturb meiosis. Evaluation of specific chemicals for potential effects on meiosis is required to elucidate the mechanism by which these chemicals act.
Third, among the four potentially sensitive developmental windows discussed in this Review, follicle assembly is the most thoroughly investigated. Several studies have reported effects of exposure to BPA and DEHP, or its metabolite MEHP, but the specific mechanisms by which these chemicals affect the process are unclear. Mechanistic knowledge is important for inter-species extrapolation. We encourage further studies to investigate the processes that are potentially sensitive to EDCs, especially apoptosis, proliferation and cell cycle. Fourth, EDCs, including BPA and DEHP, might accelerate the first follicle wave in the rodent postnatal period and that could lead exposed animals to earlier reproductive senescence than unexposed animals. We therefore believe that studies that investigate the effects of exposure to other EDCs are warranted.
When viewed together, many reproductive disorders in girls and young women -ranging from precocious puberty to PCOS and ovarian cancers -might have shared aetiologies in many instances. Mounting evidence suggests that these reproductive disorders can often be manifestations of incorrect programming during fetal life, such that together they would comprise an ovarian dysgenesis syndrome; a similar scenario was proposed for male reproductive disorders two decades ago with the testicular dysgenesis syndrome hypothesis. An increased effort into studying the underlying causes of female reproductive disorders, coupled with robust human epidemiological data, is needed. If these studies are conducted, the resulting data may contribute to safeguarding female reproductive health into the future.
In conclusion, results from animal studies can clarify the relationships between early exposure to chemicals and its effects during adult life; however, associations from human epidemiological studies in this field are difficult to interpret owing to the time lag between developmental exposure and appearance of adverse outcomes in adulthood. Furthermore, complex exposure patterns might distort the image, thus contributing to another layer of complexity. Nevertheless, an integrated evaluation of animal and human studies indicates that female reproductive health later in life can be compromised by environmental factors, including exposures to EDCs during the otherwise protected milieu of the womb.
